Application 211455
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | METHYLERGONOVINE MALEATE | METHYLERGONOVINE MALEATE | TABLET;ORAL | 0.2MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-3655 | Methylergonovine Maleate | Methylergonovine Maleate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-3655 | Methylergonovine Maleate | Methylergonovine Maleate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 17856-3655 | Methylergonovine Maleate | Methylergonovine Maleate | ATLANTIC BIOLOGICALS CORP. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 56498 | ORIG | 2018-11-16 |